Clinical Trials Browser

Active not recruiting × Various Advanced Cancer × Nivolumab × Clear all

NCT02632409 2025-10-16

CheckMate 274

Phase 3 Active not recruiting

709 enrolled 13 charts 1 FDA

Various Advanced Cancer